Showing results (151-160 of 204) with videos related to

Sort By:
Pageof 21
BMC Neurology|August 8, 2018
Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS)Marcus J Drake, Luke Canham, Nikki Cotterill, et al.
Neurourology and Urodynamics|May 29, 2018
Relaxin-2 therapy reverses radiation-induced fibrosis and restores bladder function in miceYouko Ikeda, Irina V Zabbarova, Lori A Birder, et al.
European Urology|December 7, 2010
EAU guidelines on urinary incontinenceJoachim W Thüroff, Paul Abrams, Karl-Erik Andersson, et al.
Neurourology and Urodynamics|December 4, 2023
Developing new ways to assess neural control of pelvic organ function in spinal conditions: ICI-RS 2023Katie Webb, Mathijs M de Rijk, Jerzy B Gajewski, et al.
Neurourology and Urodynamics|January 24, 2018
What are the origins and relevance of spontaneous bladder contractions? ICI-RS 2017Marcus J Drake, Christopher H Fry, Hikaru Hashitani, et al.
European Urology|July 20, 2025
From Clinical Trials to Routine Practice: Are Urodynamics Still Useful?Christopher R Chapple, Adrian Wagg, Christopher Harding, et al.
European Urology|May 15, 2024
Bladder Outlet Obstruction Relief and Symptom Improvement Following Medical and Surgical Therapies for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Systematic ReviewMassimiliano Creta, Giorgio I Russo, Naeem Bhojani, et al.
Neurourology and Urodynamics|November 18, 2017
An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD)Jerzy B Gajewski, Brigitte Schurch, Rizwan Hamid, et al.
BJU International|April 25, 2015
Responder and health-related quality of life analyses in men with lower urinary tract symptoms treated with a fixed-dose combination of solifenacin and tamsulosin oral-controlled absorption system: results from the NEPTUNE studyMarcus J Drake, Roman Sokol, Karin Coyne, et al.
International Journal of Clinical Practice|April 19, 2017
Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)Marcus J Drake, Scott MacDiarmid, Christopher R Chapple, et al.
Pageof 21